For citations:
Sergienko D.F., Golubtsova O.I., Enina E.A. Efficacy and safety of switching within one international non-proprietary name (elexacaftor/tezacaftor/ivacaftor) in children with cystic fibrosis: clinical experience of transition from Trikafta to Trilexa. Astrakhan medical journal. 2026;21(2):173-183. (In Russ.) https://doi.org/10.17021/1992-6499-2026-2-173-183
Views PDF (Rus): 57
JATS XML
Email this article 